Robert G. Spignesi Jr. - 17 May 2023 Form 4 Insider Report for RAPID MICRO BIOSYSTEMS, INC. (RPID)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jonathan Paris, Attorney-in-Fact for Robert G. Spignesi, Jr.
Issuer symbol
RPID
Transactions as of
17 May 2023
Net transactions value
+$18,204
Form type
4
Filing time
18 May 2023, 16:12:26 UTC
Previous filing
13 Mar 2023
Next filing
10 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPID Class A Common Stock Purchase $178 +200 +0.07% $0.8900 294,973 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $90.1 +100 +0.03% $0.9010 295,073 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $2,715 +3,000 +1% $0.9050 298,073 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $13,377 +14,700 +4.9% $0.9100 312,773 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $1,288 +1,400 +0.45% $0.9200 314,173 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $92.3 +100 +0.03% $0.9230 314,273 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $92.4 +100 +0.03% $0.9240 314,373 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $92.5 +100 +0.03% $0.9250 314,473 17 May 2023 Direct
transaction RPID Class A Common Stock Purchase $279 +300 +0.09% $0.9300 321,512 17 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 6,739 shares acquired under the Rapid Micro Biosystems, Inc. employee stock purchase plan on March 14, 2023.